SCHEMBL714219

SCHEMBL714219

COC=C(C(=O)O)c1cccc(C)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
KDM4E B2RXH2 3/20 0.56
HPGD P15428 3/20 0.56
HSD17B10 Q99714 2/20 0.56
KMT2A Q03164 3/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
GAA P10253 2/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RXFP1 Q9HBX9 1/20 0.37
TRPA1 O75762 1/20 0.37
MEN1 O00255 1/20 0.37
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
PLG P00747 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6265289 0.85 ERCC5 (0.46) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL7770355 0.85 ERCC5 (0.46) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL7770353 0.85 ERCC5 (0.46) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL8576220 0.79 HPGD (0.36) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL3122885 0.78 LMNA (0.52) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL4787172 0.78 LMNA (0.52) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL3122880 0.78 LMNA (0.52) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL712292 0.75 PTGER4 (0.47) HPGDKMT2AL3MBTL1SMN1; SMN2
SCHEMBL8972816 0.74 AKR1C2 (0.58) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL9333403 0.74 PPARG (0.39) ALDH1A1HSD17B10KMT2AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124761-B2 Coupling of methyl (E)-2-{2-[6-chloropyrimidin-4-yloxy]phenyl}-3-methoxyacrylate with 2-cyanophenyl in DMF with 2 mol % DABCO; significantly smaller amounts of this relatively expensive catalyst may be used without compromising the yield SYNGENTA LIMITED (GB) 2012-02-28 US disclosed
EP-2308825-A1 Process for the preparation of an intermediate for azoxystrobin Syngenta Limited (GB) 2011-04-13 EP disclosed